Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Libor Komínek"'
Autor:
Tomáš Procházka, Pavel Šlampa, Miroslav Vrzal, Marek Slávik, Iveta Selingerová, D M Blakaj, Zdenek Rehak, Tomas Kazda, Libor Komínek, P Burkon, Petr Pospíšil
Publikováno v:
Neoplasma. 66:315-325
Localized, metastasis-directed stereotactic body radiation therapy (SBRT) of oligometastatic disease (OD) is currently rapidly evolving standard of care in many institutions. Further reports of outcomes are required to strengthen the level of evidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b19e3cc08537137f283d5747d33e844e
https://doi.org/10.4149/neo_2018_180731n558
https://doi.org/10.4149/neo_2018_180731n558
Autor:
Pavel Šlampa, Tomáš Kazda, Marek Slávik, Petr Burkoň, Miroslav Vrzal, Lukas Bobek, Sabina Oberreiterová, Tomáš Procházka, Libor Komínek
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 33(2)
Background The aim of this retrospective study is to evaluate the efficacy and toxicity of extracranial stereotactic radiotherapy for the treatment of oligometastatic lymph node involvement in the mediastinum, retroperitoneum, and pelvis in a consecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c21df7114639a97610a4e015963305
https://pubmed.ncbi.nlm.nih.gov/32303132
https://pubmed.ncbi.nlm.nih.gov/32303132
Autor:
Lukas Bobek, Hana Tichá, Libor Komínek, Jana Zitterbartová, Pavel Krupa, Anna Odlozilikova, Aleš Kudláček, Pavel Šlampa, Radana Dymackova, Tomas Kazda
Publikováno v:
Biomedical Papers, Vol 160, Iss 3, Pp 435-441 (2016)
Background: Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb50536ae37a603fe7e26013e29ec66
https://biomed.papers.upol.cz/artkey/bio-201603-0016_Early_toxicity_of_hypofractionated_radiotherapy_for_prostate_cancer.php
https://biomed.papers.upol.cz/artkey/bio-201603-0016_Early_toxicity_of_hypofractionated_radiotherapy_for_prostate_cancer.php
Autor:
Petr Burkon, Iveta Selingerova, Marek Slavik, Petr Pospisil, Lukas Bobek, Libor Kominek, Pavel Osmera, Tomas Prochazka, Miroslav Vrzal, Tomas Kazda, Pavel Slampa
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
AimsTo evaluate the efficacy and toxicity of extracranial stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic lymph node involvement in the mediastinum, retroperitoneum, or pelvis, in a consecutive group of patients from real cl
Externí odkaz:
https://doaj.org/article/0fa30c1c4c92470f8e15e643b34db649
Autor:
Pavel Krupa, Hana Ticha, Tomas Kazda, Radana Dymackova, Jana Zitterbartova, Anna Odlozilikova, Libor Kominek, Lukas Bobek, Ales Kudlacek, Pavel Slampa
Publikováno v:
Biomedical Papers, Vol 160, Iss 3, Pp 435-441 (2016)
Background: Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules
Externí odkaz:
https://doaj.org/article/3436f9adb3a041d78bb6dcd445286129